LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 53.77 | 84.90 | 1196 | 6252 | 0.1913 | 0.5319 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 53.77 | 84.90 | 1219 | 6252 | 0.1950 | 0.5366 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 53.77 | 84.90 | 983 | 6252 | 0.1572 | 0.4842 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 53.77 | 84.90 | 1011 | 6252 | 0.1617 | 0.4909 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 55.48 | 84.90 | 1231 | 6567 | 0.1874 | 0.5315 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 55.48 | 84.90 | 1255 | 6567 | 0.1911 | 0.5362 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 55.48 | 84.90 | 1025 | 6567 | 0.1561 | 0.4875 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 55.48 | 84.90 | 1060 | 6567 | 0.1614 | 0.4954 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 57.18 | 84.90 | 1243 | 6963 | 0.1785 | 0.5252 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 57.18 | 84.90 | 1260 | 6963 | 0.1810 | 0.5285 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 57.18 | 84.90 | 1052 | 6963 | 0.1511 | 0.4857 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 57.18 | 84.90 | 1082 | 6963 | 0.1554 | 0.4923 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 58.88 | 84.90 | 1245 | 7291 | 0.1707 | 0.5189 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 58.88 | 84.90 | 1260 | 7291 | 0.1728 | 0.5218 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 58.88 | 84.90 | 1059 | 7291 | 0.1452 | 0.4812 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 58.88 | 84.90 | 1089 | 7291 | 0.1493 | 0.4876 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 60.59 | 84.90 | 1275 | 7641 | 0.1668 | 0.5179 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 60.59 | 84.90 | 1300 | 7641 | 0.1701 | 0.5224 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 60.59 | 84.90 | 1021 | 7641 | 0.1336 | 0.4668 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 60.59 | 84.90 | 1052 | 7641 | 0.1377 | 0.4736 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 62.29 | 84.90 | 1294 | 7934 | 0.1631 | 0.5161 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 62.29 | 84.90 | 1316 | 7934 | 0.1659 | 0.5200 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 62.29 | 84.90 | 1032 | 7934 | 0.1301 | 0.4646 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 62.29 | 84.90 | 1053 | 7934 | 0.1327 | 0.4691 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 63.99 | 84.90 | 1290 | 8212 | 0.1571 | 0.5106 | MN20160318_Q02 | C04 |